Q3 2025 13F Holders as of 9/30/2025
-
Type / Class
-
Debt / NOTE 2.250% 4/0
-
Number of holders
-
5
-
Total 13F principal, excl. options
-
3.79M
-
Principal change
-
-10.2M
-
Total reported value, excl. options
-
$29.3M
-
Value change
-
-$13.5M
-
Number of sells
-
-4
-
Price
-
$1.36
Significant Holders of ASCENDIS PHARMA A/S - NOTE 2.250% 4/0 as of Q3 2025
6 filings reported holding 04351PAD3 - ASCENDIS PHARMA A/S - NOTE 2.250% 4/0 as of Q3 2025.
ASCENDIS PHARMA A/S - NOTE 2.250% 4/0 has 5 institutional bondholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of $3.79M of principal
.
Largest 6 bondholders include Voya Investment Management LLC ($1.7M of principal), ZAZOVE ASSOCIATES LLC ($1.05M of principal), Union Bancaire Privee, UBP SA ($520K of principal), Central Pacific Bank - Trust Division ($344K of principal), SG Americas Securities, LLC ($180K of principal), and Wellesley Asset Management ($0 of principal).
This table shows the top 5 institutional bondholders of the company debt. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Principal |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.